Physician

Christopher George Meyer, M.D.

According to 2025 Medicare claims, Christopher Meyer, M.D. (NPI: 1598984155) practices rheumatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (NPI: 1780647578; TIN: 56-1426545) and primary practice location at 28803-1700. Meyer is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Meyer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 457 traditional Medicare patients, billed 150,192 HCPCS/CPT codes, and received $1,524,227 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,426 prescription claims across 437 beneficiaries totaling $3,219,183 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 55 records totaling $1,027. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,095,533 to $3,219,183. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	513	44,301	$1,029,409
2016	601	74,387	$1,434,118
2017	588	86,818	$1,838,211
2018	610	113,056	$2,191,792
2019	519	114,198	$1,993,630
2020	556	143,179	$2,295,869
2021	504	140,462	$2,071,495
2022	503	129,618	$1,759,011
2023	538	148,136	$1,730,350
2024	457	150,192	$1,524,227

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	380	4,479	$1,095,533
2016	412	4,440	$1,245,137
2017	418	4,387	$1,356,058
2018	404	3,838	$1,660,103
2019	387	3,744	$1,849,669
2020	407	3,595	$2,085,920
2021	397	3,494	$2,375,657
2022	389	3,308	$2,360,483
2023	403	3,331	$2,648,715
2024	437	3,426	$3,219,183

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	262	552	$86
36415	Insertion of needle into vein for collection of blood sample	276	596	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	274	674	$8
82565	Blood creatinine level	311	715	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	288	692	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	46	1,604	$429,067
Simponi	Golimumab	51	1,770	$350,312
Cosentyx Sensoready (2 Pens)	Secukinumab	36	1,008	$267,564
Forteo	Teriparatide	59	1,680	$248,776
Humira(Cf) Pen	Adalimumab	35	1,043	$244,246

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$1,027	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher George Meyer, M.D.?

Tedicare shows public-source Medicare data for Christopher George Meyer, M.D. (NPI 1598984155), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher George Meyer, M.D. have ACO affiliation data?

Christopher George Meyer, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Christopher George Meyer, M.D.?

Christopher George Meyer, M.D. is linked to ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (billing NPI 1780647578) in the available physician profile data.

Does Christopher George Meyer, M.D. have Open Payments data?

Christopher George Meyer, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.